Strategic Forecast 2026: Navigating the Global Hypertriglyceridemia Treatment Market
As of early 2026, the hypertriglyceridemia treatment market has entered a transformative era characterized by a shift from broad lipid management to highly targeted genetic and molecular interventions. While traditional lipid-lowering agents remain foundational, the industry is witnessing an aggressive pivot toward therapies that address the “residual risk” of cardiovascular events and acute pancreatitis. Driven … Read more